Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Go back to Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Tops Q3 EPS by 4c

November 3, 2021 4:50 PM EDT

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

... More